Qyuns Therapeutics Co (HKSE:02509) Buyback Yield %: 0.00 (As of Sep. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02509 Qyuns Therapeutics Co Ltd HKSE:02509
9 GF Score
Price HK$16.44
! 5 Warning Signs
View Full Analysis

What is Qyuns Therapeutics Co Buyback Yield %?

Qyuns Therapeutics Co HKSE:02509 -1.32% 9 Buyback Yield % is 0.00 as of Sep. 01, 2026. GuruFocus rates HKSE:02509 with a GF Score™ of 9/100. The stock has 5 warning signs investors should review. Among 699 Biotechnology companies, Qyuns Therapeutics Co ranks worse than 143061.37% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Qyuns Therapeutics Co's current buyback yield was 0.00%.

Qyuns Therapeutics Co Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Qyuns Therapeutics Co's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qyuns Therapeutics Co Buyback Yield % Chart

Qyuns Therapeutics Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
0.00 0.00 0.00 -12.80 -1.64

Qyuns Therapeutics Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only -5.21 -12.80 0.00 -1.64 0.00

HKSE:02509 vs VRTX, REGN, MRNA: Buyback Yield % Comparison

For the Biotechnology subindustry, Qyuns Therapeutics Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qyuns Therapeutics Co Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Qyuns Therapeutics Co's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Qyuns Therapeutics Co's Buyback Yield % falls into.


HKSE:02509
9GF Score
Qyuns Therapeutics Co Ltd HKSE:02509
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qyuns Therapeutics Co Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Qyuns Therapeutics Co's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-30.041 + 100.499) / 4308.196
=-1.64%

Qyuns Therapeutics Co's annualized Buyback Yield for the quarter that ended in Jun. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 3167.55676
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Qyuns Therapeutics Co (HKSE:02509) has a Buyback Yield % of 0.00 as of Sep. 01, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Qyuns Therapeutics Co and its competitors. According to the industry distribution chart, Qyuns Therapeutics Co ranks #999999 out of 699 companies in the Biotechnology industry.
Is Qyuns Therapeutics Co's Buyback Yield % too high?
Qyuns Therapeutics Co's current Buyback Yield % is 0.00. Based on the distribution chart, Qyuns Therapeutics Co ranks #999999 out of 699 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Qyuns Therapeutics Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Qyuns Therapeutics Co's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Qyuns Therapeutics Co ranks #999999 out of 699 companies for Buyback Yield %. This places Qyuns Therapeutics Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Qyuns Therapeutics Co and its competitors. Qyuns Therapeutics Co's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qyuns Therapeutics Co stock overvalued right now?
Qyuns Therapeutics Co (HKSE:02509) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Qyuns Therapeutics Co's overall GF Score™ is 9/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Qyuns Therapeutics Co (HKSE:02509), the current Buyback Yield % is 0.00 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Qyuns Therapeutics Co Business Description

Address No. 907 Yaocheng Avenue, Room 1310, Building 1, Taizhou, Jiangsu, CHN
Qyuns Therapeutics Co Ltd is a clinical-stage biotech company focused on biologic therapies for autoimmune and allergic diseases, with a self-developed drug pipeline. It has built a pipeline that covers the four disease areas in the field, including skin, rheumatic, respiratory, and digestive diseases. The group is principally engaged in the research and development, manufacturing, and commercialisation of biologic therapies for autoimmune and allergic diseases. Key revenue is generated from the PRC.
9GF Score

Get the complete analysis for HKSE:02509

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$16.44
Price